139 related articles for article (PubMed ID: 22348544)
1. The reality of an intermediate type between asthma and COPD in practice.
Kim TB; Oh YM; Chang YS; Cho YS; Jang AS; Cho SH; Choi BW; Lee SD; Moon HB; ;
Respir Care; 2012 Aug; 57(8):1248-53. PubMed ID: 22348544
[TBL] [Abstract][Full Text] [Related]
2. Consensus document on the overlap phenotype COPD-asthma in COPD.
Soler-Cataluña JJ; Cosío B; Izquierdo JL; López-Campos JL; Marín JM; Agüero R; Baloira A; Carrizo S; Esteban C; Galdiz JB; González MC; Miravitlles M; Monsó E; Montemayor T; Morera J; Ortega F; Peces-Barba G; Puente L; Rodríguez JM; Sala E; Sauleda J; Soriano JB; Viejo JL
Arch Bronconeumol; 2012 Sep; 48(9):331-7. PubMed ID: 22341911
[TBL] [Abstract][Full Text] [Related]
3. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
[TBL] [Abstract][Full Text] [Related]
4. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country.
Musafiri S; van Meerbeeck J; Musango L; Brusselle G; Joos G; Seminega B; Rutayisire C
Respir Med; 2011 Nov; 105(11):1596-605. PubMed ID: 21783353
[TBL] [Abstract][Full Text] [Related]
6. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
7. Chronic obstructive pulmonary disease is missed in asthmatics in specialty care in Trinidad, West Indies.
Pinto Pereira LM; Bartholomew LA; Brooks H; Lowe D; Rocke K; Rolle S; Smith J; Thekwini O; Seemungal TA; Bekele I
Int J Tuberc Lung Dis; 2007 Sep; 11(9):1026-32. PubMed ID: 17705983
[TBL] [Abstract][Full Text] [Related]
8. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease.
Shirtcliffe P; Marsh S; Travers J; Weatherall M; Beasley R
Intern Med J; 2012 Jan; 42(1):83-8. PubMed ID: 20403069
[TBL] [Abstract][Full Text] [Related]
9. Using post-bronchodilator FEV₁ is better than pre-bronchodilator FEV₁ in evaluation of COPD severity.
Chen CZ; Ou CY; Wang WL; Lee CH; Lin CC; Chang HY; Hsiue TR
COPD; 2012 Jun; 9(3):276-80. PubMed ID: 22360379
[TBL] [Abstract][Full Text] [Related]
10. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
Chhabra SK; Bhatnagar S
Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
Ágh T; Inotai A; Mészáros Á
Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
[TBL] [Abstract][Full Text] [Related]
13. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
[TBL] [Abstract][Full Text] [Related]
14. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome.
Nakawah MO; Hawkins C; Barbandi F
J Am Board Fam Med; 2013; 26(4):470-7. PubMed ID: 23833163
[TBL] [Abstract][Full Text] [Related]
15. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of lung volume response with airflow response to bronchodilator in patients with chronic obstructive pulmonary disease].
Zhang FQ; Zheng JP; Wang JH; Lu WB; Wu RX; Li XS; Xian QZ; Gao Y; Jiang M
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):109-13. PubMed ID: 20367950
[TBL] [Abstract][Full Text] [Related]
17. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea.
Kim SJ; Suk MH; Choi HM; Kimm KC; Jung KH; Lee SY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
Int J Tuberc Lung Dis; 2006 Dec; 10(12):1393-8. PubMed ID: 17167958
[TBL] [Abstract][Full Text] [Related]
18. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA
Respiration; 2011; 82(1):19-27. PubMed ID: 21282939
[TBL] [Abstract][Full Text] [Related]
19. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
20. Differentiating COPD from asthma in clinical practice.
Chang J; Mosenifar Z
J Intensive Care Med; 2007; 22(5):300-9. PubMed ID: 17895488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]